PMCID
string | Sentences
string | ner
list |
|---|---|---|
PMC11806818
|
B The synthesis process of MoS2-MIL-101(Fe) and schematic diagram of exosome detection mechanism of the proposed method.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"B",
"The",
"synthesis",
"process",
"of",
"MoS2-MIL-101(Fe",
")",
"and",
"schematic",
"diagram",
"of",
"exosome",
"detection",
"mechanism",
"of",
"the",
"proposed",
"method",
"."
]
}
] |
PMC11700523
|
IS accumulation was observed in the damaged tubules in the 5/6 Nx rat model.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"IS",
"accumulation",
"was",
"observed",
"in",
"the",
"damaged",
"tubules",
"in",
"the",
"5/6",
"Nx",
"rat",
"model",
"."
]
}
] |
PMC6835428
|
OCs of epithelial origin have been further subdivided into (Figure 1): type I tumors, which contain well-differentiated cells (such as low grade serous carcinoma and endometrioid carcinoma) and are characterized by low malignity; type II tumors, which are rather aggressive and arise directly from the epithelial tissue of the organ without going through a precancerous phase (typically represented by the high-grade serous ovarian carcinomas—HGSOCs) .
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"OCs",
"of",
"epithelial",
"origin",
"have",
"been",
"further",
"subdivided",
"into",
"(",
"Figure",
"1",
"):",
"type",
"I",
"tumors",
",",
"which",
"contain",
"well-differentiated",
"cells",
"(",
"such",
"as",
"low",
"grade",
"serous",
"carcinoma",
"and",
"endometrioid",
"carcinoma",
")",
"and",
"are",
"characterized",
"by",
"low",
"malignity",
";",
"type",
"II",
"tumors",
",",
"which",
"are",
"rather",
"aggressive",
"and",
"arise",
"directly",
"from",
"the",
"epithelial",
"tissue",
"of",
"the",
"organ",
"without",
"going",
"through",
"a",
"precancerous",
"phase",
"(",
"typically",
"represented",
"by",
"the",
"high-grade",
"serous",
"ovarian",
"carcinomas",
"—",
"HGSOCs",
")",
"."
]
}
] |
PMC11394227
|
It was hypothesized that this was due to the rapid folding of disulfide bonds in CHO-PAb-QS cells, resulting in fewer unfolded and misfolded proteins.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"B-CellLine",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"It",
"was",
"hypothesized",
"that",
"this",
"was",
"due",
"to",
"the",
"rapid",
"folding",
"of",
"disulfide",
"bonds",
"in",
"CHO-PAb-QS",
"cells",
",",
"resulting",
"in",
"fewer",
"unfolded",
"and",
"misfolded",
"proteins",
"."
]
}
] |
PMC6133382
|
However, the ultimate utility of this cell line will require characterization of stable cell lines with transfected envelope proteins in which the genetic stability of the transgene as well as the quality and yield of the final product is determined.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"However",
",",
"the",
"ultimate",
"utility",
"of",
"this",
"cell",
"line",
"will",
"require",
"characterization",
"of",
"stable",
"cell",
"lines",
"with",
"transfected",
"envelope",
"proteins",
"in",
"which",
"the",
"genetic",
"stability",
"of",
"the",
"transgene",
"as",
"well",
"as",
"the",
"quality",
"and",
"yield",
"of",
"the",
"final",
"product",
"is",
"determined",
"."
]
}
] |
PMC7369657
|
CQDs induced cytotoxicity in the 143B cell line through the mitochondrial apoptotic signaling pathway.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"B-CellLine",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"CQDs",
"induced",
"cytotoxicity",
"in",
"the",
"143B",
"cell",
"line",
"through",
"the",
"mitochondrial",
"apoptotic",
"signaling",
"pathway",
"."
]
}
] |
PMC11055323
|
The SW982 cells stably expressed empty vector, wild-type SS18-SSX1 and its mutants were seeded at 1000 cells per well in six-well plates.
|
[
{
"tags": [
"O",
"B-CellLine",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"B-CellLine",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"The",
"SW982",
"cells",
"stably",
"expressed",
"empty",
"vector",
",",
"wild-type",
"SS18-SSX1",
"and",
"its",
"mutants",
"were",
"seeded",
"at",
"1000",
"cells",
"per",
"well",
"in",
"six-well",
"plates",
"."
]
}
] |
PMC11763111
|
To account for the short lifespan of NK cells compared to T and B cells , NK cells were administered a second time on day 7 after the initial injection (Fig. 7A).
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"To",
"account",
"for",
"the",
"short",
"lifespan",
"of",
"NK",
"cells",
"compared",
"to",
"T",
"and",
"B",
"cells",
",",
"NK",
"cells",
"were",
"administered",
"a",
"second",
"time",
"on",
"day",
"7",
"after",
"the",
"initial",
"injection",
"(",
"Fig.",
"7A",
")",
"."
]
}
] |
PMC8973725
|
The results of CCK-8 assay showed that cell viability was reduced at 24, 48, and 72 h in ZNF677-expressing cells (Figure 4b), while a reduction of approximately 70–80% in colony formation was observed in ZNF677-expressing cells compared to control cells (Figure 4c).
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"The",
"results",
"of",
"CCK-8",
"assay",
"showed",
"that",
"cell",
"viability",
"was",
"reduced",
"at",
"24",
",",
"48",
",",
"and",
"72",
"h",
"in",
"ZNF677-expressing",
"cells",
"(",
"Figure",
"4b",
")",
",",
"while",
"a",
"reduction",
"of",
"approximately",
"70–80",
"%",
"in",
"colony",
"formation",
"was",
"observed",
"in",
"ZNF677-expressing",
"cells",
"compared",
"to",
"control",
"cells",
"(",
"Figure",
"4c",
")",
"."
]
}
] |
PMC9622879
|
For the LEC with communal DERs, a system-centric CEMS with an operator is usually needed to control and provide their energy to every home optimistically.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"For",
"the",
"LEC",
"with",
"communal",
"DERs",
",",
"a",
"system-centric",
"CEMS",
"with",
"an",
"operator",
"is",
"usually",
"needed",
"to",
"control",
"and",
"provide",
"their",
"energy",
"to",
"every",
"home",
"optimistically",
"."
]
}
] |
PMC9429973
|
Secondary endpoints include the composite end point of infection and warts, infection rates and severity, change from baseline in cutaneous warts, and number of hours above absolute lymphocyte count (ALC) of ≥1000 cells/µL over a 24-hour period, and patient-reported quality-of-life assessment using age-appropriate questionnaires.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Secondary",
"endpoints",
"include",
"the",
"composite",
"end",
"point",
"of",
"infection",
"and",
"warts",
",",
"infection",
"rates",
"and",
"severity",
",",
"change",
"from",
"baseline",
"in",
"cutaneous",
"warts",
",",
"and",
"number",
"of",
"hours",
"above",
"absolute",
"lymphocyte",
"count",
"(",
"ALC",
")",
"of",
"≥1000",
"cells/µL",
"over",
"a",
"24-hour",
"period",
",",
"and",
"patient-reported",
"quality-of-life",
"assessment",
"using",
"age-appropriate",
"questionnaires",
"."
]
}
] |
PMC10073922
|
In doing so, A549 cells were transfected with NDRG2 or mock plasmids, as described previously.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"B-CellLine",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"In",
"doing",
"so",
",",
"A549",
"cells",
"were",
"transfected",
"with",
"NDRG2",
"or",
"mock",
"plasmids",
",",
"as",
"described",
"previously",
"."
]
}
] |
PMC9429973
|
Grade ≥3 adverse events (AEs) with gilteritinib (97.3%) vs SC (94.2%) were comparable; serious AE rates were higher for gilteritinib (73.5%) vs SC (61.5%).
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Grade",
"≥3",
"adverse",
"events",
"(",
"AEs",
")",
"with",
"gilteritinib",
"(",
"97.3",
"%",
")",
"vs",
"SC",
"(",
"94.2",
"%",
")",
"were",
"comparable",
";",
"serious",
"AE",
"rates",
"were",
"higher",
"for",
"gilteritinib",
"(",
"73.5",
"%",
")",
"vs",
"SC",
"(",
"61.5",
"%",
")",
"."
]
}
] |
PMC9429973
|
Two of these patients relapsed with CD38 ALL 5 and 7 months after SCT, respectively.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Two",
"of",
"these",
"patients",
"relapsed",
"with",
"CD38",
"ALL",
"5",
"and",
"7",
"months",
"after",
"SCT",
",",
"respectively",
"."
]
}
] |
PMC11575040
|
By integrating the top 100 candidates from TargetScan and miRDB, we identified 22 putative miR-1270 targets (Fig. 8A).
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"By",
"integrating",
"the",
"top",
"100",
"candidates",
"from",
"TargetScan",
"and",
"miRDB",
",",
"we",
"identified",
"22",
"putative",
"miR-1270",
"targets",
"(",
"Fig.",
"8A",
")",
"."
]
}
] |
PMC11721587
|
Both S482A and AAV mutations abolished the formation of the SDS-resistant Fu dimer (Fig. 2C and fig. S3A), suggesting that Fu-R phosphorylation is essential for Fu maturation.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Both",
"S482A",
"and",
"AAV",
"mutations",
"abolished",
"the",
"formation",
"of",
"the",
"SDS-resistant",
"Fu",
"dimer",
"(",
"Fig.",
"2C",
"and",
"fig.",
"S3A",
")",
",",
"suggesting",
"that",
"Fu-R",
"phosphorylation",
"is",
"essential",
"for",
"Fu",
"maturation",
"."
]
}
] |
PMC9429973
|
Image: Summary/Conclusion: IRd appeared to be effective in RRMM pts in routine clinical practice regardless of prior LEN or PI exposure, with better outcomes seen in LEN- &/or PI-non-refractory vs -refractory pts.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Image",
":",
"Summary/Conclusion",
":",
"IRd",
"appeared",
"to",
"be",
"effective",
"in",
"RRMM",
"pts",
"in",
"routine",
"clinical",
"practice",
"regardless",
"of",
"prior",
"LEN",
"or",
"PI",
"exposure",
",",
"with",
"better",
"outcomes",
"seen",
"in",
"LEN-",
"&",
"/or",
"PI-non-refractory",
"vs",
"-refractory",
"pts",
"."
]
}
] |
PMC11180402
|
Migrated cells on the underside of the insert were counted using an Olympus DP71 microscope (Olympus, Center Valley, PA) across eight randomly selected fields at 50 × magnification.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Migrated",
"cells",
"on",
"the",
"underside",
"of",
"the",
"insert",
"were",
"counted",
"using",
"an",
"Olympus",
"DP71",
"microscope",
"(",
"Olympus",
",",
"Center",
"Valley",
",",
"PA",
")",
"across",
"eight",
"randomly",
"selected",
"fields",
"at",
"50",
"×",
"magnification",
"."
]
}
] |
PMC8409415
|
In the A2780 xenograft model, tumor size in the cisplatin treatment group was significantly more suppressed than that in the PBS group on day 16 after drug administration (841.9 vs 1991.5 mm, P < .05).
|
[
{
"tags": [
"O",
"O",
"B-CellLine",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"In",
"the",
"A2780",
"xenograft",
"model",
",",
"tumor",
"size",
"in",
"the",
"cisplatin",
"treatment",
"group",
"was",
"significantly",
"more",
"suppressed",
"than",
"that",
"in",
"the",
"PBS",
"group",
"on",
"day",
"16",
"after",
"drug",
"administration",
"(",
"841.9",
"vs",
"1991.5",
"mm",
",",
"P",
"<",
".05",
")",
"."
]
}
] |
PMC9429973
|
We quantified the relative surface expression of BTN2A (using 107G3B5 and 7.48 mAbs) and BTN3A (using 20.1 and 108.5 mAbs) on cell lines and primary ALL blasts.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"We",
"quantified",
"the",
"relative",
"surface",
"expression",
"of",
"BTN2A",
"(",
"using",
"107G3B5",
"and",
"7.48",
"mAbs",
")",
"and",
"BTN3A",
"(",
"using",
"20.1",
"and",
"108.5",
"mAbs",
")",
"on",
"cell",
"lines",
"and",
"primary",
"ALL",
"blasts",
"."
]
}
] |
PMC11078693
|
Alternatives: Any confocal microscope can be used for imaging.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Alternatives",
":",
"Any",
"confocal",
"microscope",
"can",
"be",
"used",
"for",
"imaging",
"."
]
}
] |
PMC11751675
|
Furthermore, artemisinin (8) and dihydroartemisinin (25) formed the highest number of conventional hydrogen bonds, comparable to chloroquine (the reference compound).
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Furthermore",
",",
"artemisinin",
"(",
"8)",
"and",
"dihydroartemisinin",
"(",
"25",
")",
"formed",
"the",
"highest",
"number",
"of",
"conventional",
"hydrogen",
"bonds",
",",
"comparable",
"to",
"chloroquine",
"(",
"the",
"reference",
"compound",
")",
"."
]
}
] |
PMC3813807
|
These findings are in agreement with a previous report demonstrating that miR-373 has oncogenic properties (11).
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"These",
"findings",
"are",
"in",
"agreement",
"with",
"a",
"previous",
"report",
"demonstrating",
"that",
"miR-373",
"has",
"oncogenic",
"properties",
"(",
"11",
")",
"."
]
}
] |
PMC11026382
|
Nearly all mutations are contained in the near-neutral peak, including mutations at highly conserved active site positions like M20, W22, and L28.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Nearly",
"all",
"mutations",
"are",
"contained",
"in",
"the",
"near-neutral",
"peak",
",",
"including",
"mutations",
"at",
"highly",
"conserved",
"active",
"site",
"positions",
"like",
"M20",
",",
"W22",
",",
"and",
"L28",
"."
]
}
] |
PMC11569208
|
according to manufacturer’s protocol and quantified using a NanoDrop™ One Microvolume UV-Vis Spectrophotometer (Thermo Fisher Scientific, Rockford, IL).
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"according",
"to",
"manufacturer",
"’s",
"protocol",
"and",
"quantified",
"using",
"a",
"NanoDrop",
"™",
"One",
"Microvolume",
"UV-Vis",
"Spectrophotometer",
"(",
"Thermo",
"Fisher",
"Scientific",
",",
"Rockford",
",",
"IL",
")",
"."
]
}
] |
PMC6222726
|
The only phytochemical study on this species was reported by Koulman, who found 5′-desmethoxy yatein [bursehernin or (−)-trans-methylpluviatolide (+)-trans-methylpluviatolide, which has been called dextrobursehernin (18)], morelensin (16), deoxypodophyllotoxin (15), and β-peltatin-A methylether (13).
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"The",
"only",
"phytochemical",
"study",
"on",
"this",
"species",
"was",
"reported",
"by",
"Koulman",
",",
"who",
"found",
"5′-desmethoxy",
"yatein",
"[",
"bursehernin",
"or",
"(−)-trans-methylpluviatolide",
"(+)-trans-methylpluviatolide",
",",
"which",
"has",
"been",
"called",
"dextrobursehernin",
"(",
"18",
")",
"]",
",",
"morelensin",
"(",
"16",
")",
",",
"deoxypodophyllotoxin",
"(",
"15",
")",
",",
"and",
"β-peltatin-A",
"methylether",
"(",
"13",
")",
"."
]
}
] |
PMC11803149
|
Proteins on the gel were transferred on PVDF (Trans-Blot Turbo™ Mini PVDF, Bio-Rad, 1704156) membrane.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Proteins",
"on",
"the",
"gel",
"were",
"transferred",
"on",
"PVDF",
"(",
"Trans-Blot",
"Turbo",
"™",
"Mini",
"PVDF",
",",
"Bio-Rad",
",",
"1704156",
")",
"membrane",
"."
]
}
] |
PMC11756514
|
We included two nonencapsulated S. pneumoniae strains ATCC12213 and C-mutant that produce WTA (also known as C-polysaccharide) and LTA (also known as F-antigen), which would be exposed in the absence of CP.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"We",
"included",
"two",
"nonencapsulated",
"S.",
"pneumoniae",
"strains",
"ATCC12213",
"and",
"C-mutant",
"that",
"produce",
"WTA",
"(",
"also",
"known",
"as",
"C-polysaccharide",
")",
"and",
"LTA",
"(",
"also",
"known",
"as",
"F-antigen",
")",
",",
"which",
"would",
"be",
"exposed",
"in",
"the",
"absence",
"of",
"CP",
"."
]
}
] |
PMC4270159
|
To assess any effects, the secondary kinase inhibitor may be independent of the ligand and primary kinase inhibitor.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"To",
"assess",
"any",
"effects",
",",
"the",
"secondary",
"kinase",
"inhibitor",
"may",
"be",
"independent",
"of",
"the",
"ligand",
"and",
"primary",
"kinase",
"inhibitor",
"."
]
}
] |
PMC11194678
|
Though mounting evidence has demonstrated that the transition from a physiological liquid phase to a pathological solid phase may cause abnormal protein aggregation related to the onset and progression of various human diseases, including neurodegenerative disorders (Alberti and Hyman, 2021; Ross and Poirier, 2004), this study provides a case that excessive LLPS could exacerbate the aberrant phase separation/transition processes of these toxic proteins.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Though",
"mounting",
"evidence",
"has",
"demonstrated",
"that",
"the",
"transition",
"from",
"a",
"physiological",
"liquid",
"phase",
"to",
"a",
"pathological",
"solid",
"phase",
"may",
"cause",
"abnormal",
"protein",
"aggregation",
"related",
"to",
"the",
"onset",
"and",
"progression",
"of",
"various",
"human",
"diseases",
",",
"including",
"neurodegenerative",
"disorders",
"(",
"Alberti",
"and",
"Hyman",
",",
"2021",
";",
"Ross",
"and",
"Poirier",
",",
"2004",
")",
",",
"this",
"study",
"provides",
"a",
"case",
"that",
"excessive",
"LLPS",
"could",
"exacerbate",
"the",
"aberrant",
"phase",
"separation/transition",
"processes",
"of",
"these",
"toxic",
"proteins",
"."
]
}
] |
PMC8992508
|
In the Hoechst 33342 accumulation assay toward the BCRP overexpressing MDCK II cell line, compounds 46 and 47 were the most potent inhibitors with a 3-fold higher potency than Ko143(5) (IC50 = 69.9, 80.0 and 221 nM, respectively).
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"B-CellLine",
"I-CellLine",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"In",
"the",
"Hoechst",
"33342",
"accumulation",
"assay",
"toward",
"the",
"BCRP",
"overexpressing",
"MDCK",
"II",
"cell",
"line",
",",
"compounds",
"46",
"and",
"47",
"were",
"the",
"most",
"potent",
"inhibitors",
"with",
"a",
"3-fold",
"higher",
"potency",
"than",
"Ko143(5",
")",
"(",
"IC50",
"=",
"69.9",
",",
"80.0",
"and",
"221",
"nM",
",",
"respectively",
")",
"."
]
}
] |
PMC8345486
|
In summary, the results indicated the inhibition of the growth of A2780cisR cells cultured with compound 2, with a simultaneous increase in drug resistance.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"B-CellLine",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"In",
"summary",
",",
"the",
"results",
"indicated",
"the",
"inhibition",
"of",
"the",
"growth",
"of",
"A2780cisR",
"cells",
"cultured",
"with",
"compound",
"2",
",",
"with",
"a",
"simultaneous",
"increase",
"in",
"drug",
"resistance",
"."
]
}
] |
PMC11806818
|
However, the complexity of its operational steps and low detection accuracy have hindered the development of immunosensor detection methods.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"However",
",",
"the",
"complexity",
"of",
"its",
"operational",
"steps",
"and",
"low",
"detection",
"accuracy",
"have",
"hindered",
"the",
"development",
"of",
"immunosensor",
"detection",
"methods",
"."
]
}
] |
PMC11106977
|
Massaccesi’s group reported that Vitamin E significantly increased levels of OGT, improving the ability of osteoblasts to respond to oxidative stress and ultimately reducing osteolysis caused by oxidation (Fig. 5) .
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Massaccesi",
"’s",
"group",
"reported",
"that",
"Vitamin",
"E",
"significantly",
"increased",
"levels",
"of",
"OGT",
",",
"improving",
"the",
"ability",
"of",
"osteoblasts",
"to",
"respond",
"to",
"oxidative",
"stress",
"and",
"ultimately",
"reducing",
"osteolysis",
"caused",
"by",
"oxidation",
"(",
"Fig.",
"5",
")",
"."
]
}
] |
PMC11541409
|
LOF mutations in NF1 lead to deregulated activation of the RAS/MAPK pathway, contributing to the tumorigenesis of GIST .
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"LOF",
"mutations",
"in",
"NF1",
"lead",
"to",
"deregulated",
"activation",
"of",
"the",
"RAS/MAPK",
"pathway",
",",
"contributing",
"to",
"the",
"tumorigenesis",
"of",
"GIST",
"."
]
}
] |
PMC11687167
|
One study showed that 3 months of methotrexate monotherapy reduced PCSK9 levels and improved psoriasis, indicating that PSCK9 could be used as a marker of psoriasis activity .
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"One",
"study",
"showed",
"that",
"3",
"months",
"of",
"methotrexate",
"monotherapy",
"reduced",
"PCSK9",
"levels",
"and",
"improved",
"psoriasis",
",",
"indicating",
"that",
"PSCK9",
"could",
"be",
"used",
"as",
"a",
"marker",
"of",
"psoriasis",
"activity",
"."
]
}
] |
PMC11697189
|
Additionally, the impact of HSPA7 on the viability and cell cycle of ccRCC cells was also investigated.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Additionally",
",",
"the",
"impact",
"of",
"HSPA7",
"on",
"the",
"viability",
"and",
"cell",
"cycle",
"of",
"ccRCC",
"cells",
"was",
"also",
"investigated",
"."
]
}
] |
PMC11763111
|
All data are presented as mean ± SEM and analyzed by two-tailed unpaired Student's t-test, except noted by one-way ANOVA and log-rank test (Mantel-Cox). *
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"All",
"data",
"are",
"presented",
"as",
"mean",
"±",
"SEM",
"and",
"analyzed",
"by",
"two-tailed",
"unpaired",
"Student",
"'s",
"t-test",
",",
"except",
"noted",
"by",
"one-way",
"ANOVA",
"and",
"log-rank",
"test",
"(",
"Mantel-Cox",
")",
".",
"*"
]
}
] |
PMC11075223
|
FA (0 ~ 40 μM) had an effect on fibroblast growth factor receptor 1-induced phosphatidylinositol 3-kinase (PI3K)-protein kinase B (Akt) pathway, resulting in repressing the proliferation of melanoma cells and angiogenesis .
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"FA",
"(",
"0",
"~",
"40",
"μM",
")",
"had",
"an",
"effect",
"on",
"fibroblast",
"growth",
"factor",
"receptor",
"1-induced",
"phosphatidylinositol",
"3-kinase",
"(PI3K)-protein",
"kinase",
"B",
"(",
"Akt",
")",
"pathway",
",",
"resulting",
"in",
"repressing",
"the",
"proliferation",
"of",
"melanoma",
"cells",
"and",
"angiogenesis",
"."
]
}
] |
PMC11495567
|
Without the carboxyl terminal posttranslational modifications that are essential for their functional localization, their growth signaling will be impaired.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Without",
"the",
"carboxyl",
"terminal",
"posttranslational",
"modifications",
"that",
"are",
"essential",
"for",
"their",
"functional",
"localization",
",",
"their",
"growth",
"signaling",
"will",
"be",
"impaired",
"."
]
}
] |
PMC11697189
|
Fig. 7Correlation analysis between risk score and tumor infiltrating immune cells. (
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Fig.",
"7Correlation",
"analysis",
"between",
"risk",
"score",
"and",
"tumor",
"infiltrating",
"immune",
"cells",
".",
"("
]
}
] |
PMC9429973
|
Response rates were similar between Cld and Pt, as described in literature.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Response",
"rates",
"were",
"similar",
"between",
"Cld",
"and",
"Pt",
",",
"as",
"described",
"in",
"literature",
"."
]
}
] |
PMC11723947
|
It has, for example, been documented that domain-swapping between different paralogs can affect their respective nuclear localization and biological function.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"It",
"has",
",",
"for",
"example",
",",
"been",
"documented",
"that",
"domain-swapping",
"between",
"different",
"paralogs",
"can",
"affect",
"their",
"respective",
"nuclear",
"localization",
"and",
"biological",
"function",
"."
]
}
] |
PMC11640555
|
Furthermore, to confirm the ability of the casein kinase 2 inhibitor (CX-4945) to arrest the proliferation of U-87 cells, the colony formation assay was performed (Figure 1E–H, score Figure 1I), and the results obtained demonstrate that CX-4945 significantly counteracted cell proliferation in a concentration-dependent manner (Figure 1E–H, score Figure 1I) compared to the control group (Figure 1E, score Figure 1I).
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"B-CellLine",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Furthermore",
",",
"to",
"confirm",
"the",
"ability",
"of",
"the",
"casein",
"kinase",
"2",
"inhibitor",
"(",
"CX-4945",
")",
"to",
"arrest",
"the",
"proliferation",
"of",
"U-87",
"cells",
",",
"the",
"colony",
"formation",
"assay",
"was",
"performed",
"(",
"Figure",
"1E",
"–",
"H",
",",
"score",
"Figure",
"1I",
")",
",",
"and",
"the",
"results",
"obtained",
"demonstrate",
"that",
"CX-4945",
"significantly",
"counteracted",
"cell",
"proliferation",
"in",
"a",
"concentration-dependent",
"manner",
"(",
"Figure",
"1E",
"–",
"H",
",",
"score",
"Figure",
"1I",
")",
"compared",
"to",
"the",
"control",
"group",
"(",
"Figure",
"1E",
",",
"score",
"Figure",
"1I",
")",
"."
]
}
] |
PMC11495567
|
The number of invaded cells was determined using the NIS-Elements and analyzed by One-Way ANOVA with Dunnett’s posthoc test, statistical significance (*p < 0.05, **p < 0.01, and ***p< 0.001).
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"The",
"number",
"of",
"invaded",
"cells",
"was",
"determined",
"using",
"the",
"NIS-Elements",
"and",
"analyzed",
"by",
"One-Way",
"ANOVA",
"with",
"Dunnett",
"’s",
"posthoc",
"test",
",",
"statistical",
"significance",
"(",
"*",
"p",
"<",
"0.05",
",",
"*",
"*",
"p",
"<",
"0.01",
",",
"and",
"*",
"*",
"*",
"p",
"<",
"0.001",
")",
"."
]
}
] |
PMC11437637
|
Lymphocyte imbalance is known to lead to abnormal cytokine secretion and inflammation, which leads to disease progression [10, 31–33].
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Lymphocyte",
"imbalance",
"is",
"known",
"to",
"lead",
"to",
"abnormal",
"cytokine",
"secretion",
"and",
"inflammation",
",",
"which",
"leads",
"to",
"disease",
"progression",
"[",
"10",
",",
"31–33",
"]",
"."
]
}
] |
PMC11593713
|
The Minimum Essential Medium with Earle’s BSS (Sartorius, Göttingen, Germany) for A549 and HeLa cell lines and Dulbeco’s Minimum Essential Medium with Earle’s BSS with an addition of 10% fetal bovine serum (FBS) (Sartorius, Göttingen, Germany) for HT-29 cell line were used as growing medium.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"B-CellLine",
"O",
"B-CellLine",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"B-CellLine",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"The",
"Minimum",
"Essential",
"Medium",
"with",
"Earle",
"’s",
"BSS",
"(",
"Sartorius",
",",
"Göttingen",
",",
"Germany",
")",
"for",
"A549",
"and",
"HeLa",
"cell",
"lines",
"and",
"Dulbeco",
"’s",
"Minimum",
"Essential",
"Medium",
"with",
"Earle",
"’s",
"BSS",
"with",
"an",
"addition",
"of",
"10",
"%",
"fetal",
"bovine",
"serum",
"(",
"FBS",
")",
"(",
"Sartorius",
",",
"Göttingen",
",",
"Germany",
")",
"for",
"HT-29",
"cell",
"line",
"were",
"used",
"as",
"growing",
"medium",
"."
]
}
] |
PMC6461034
|
Viability of PDX‐derived organoids in response to target inhibition.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Viability",
"of",
"PDX‐derived",
"organoids",
"in",
"response",
"to",
"target",
"inhibition",
"."
]
}
] |
PMC11281366
|
This standard curve was generated by extracting and amplifying DNA from serially diluted ACH-2 cells, which contain a single integrated copy of HIV-1 (NIH HIV Reagent Program).
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"B-CellLine",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"This",
"standard",
"curve",
"was",
"generated",
"by",
"extracting",
"and",
"amplifying",
"DNA",
"from",
"serially",
"diluted",
"ACH-2",
"cells",
",",
"which",
"contain",
"a",
"single",
"integrated",
"copy",
"of",
"HIV-1",
"(",
"NIH",
"HIV",
"Reagent",
"Program",
")",
"."
]
}
] |
PMC11244823
|
Luciferase activity was determined in the soluble contents of the supernatants before each of them was diluted to a starting luciferase activity of 10 RLU/50 μL. Next, a LIPS assay using an anti-V5 monoclonal antibody (mAb) was done with each soluble antigen.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Luciferase",
"activity",
"was",
"determined",
"in",
"the",
"soluble",
"contents",
"of",
"the",
"supernatants",
"before",
"each",
"of",
"them",
"was",
"diluted",
"to",
"a",
"starting",
"luciferase",
"activity",
"of",
"10",
"RLU/50",
"μL.",
"Next",
",",
"a",
"LIPS",
"assay",
"using",
"an",
"anti-V5",
"monoclonal",
"antibody",
"(",
"mAb",
")",
"was",
"done",
"with",
"each",
"soluble",
"antigen",
"."
]
}
] |
PMC11172027
|
The use of 250 and 500 µg/mL of NALM after 72 h of incubation on Jurkat cells also showed no difference to the initial control.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"B-CellLine",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"The",
"use",
"of",
"250",
"and",
"500",
"µg/mL",
"of",
"NALM",
"after",
"72",
"h",
"of",
"incubation",
"on",
"Jurkat",
"cells",
"also",
"showed",
"no",
"difference",
"to",
"the",
"initial",
"control",
"."
]
}
] |
PMC10522430
|
The G. applanatum extract was obtained via boiling distilled water.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"The",
"G.",
"applanatum",
"extract",
"was",
"obtained",
"via",
"boiling",
"distilled",
"water",
"."
]
}
] |
PMC11078693
|
Check that the coated side of the cover glass is facing up.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Check",
"that",
"the",
"coated",
"side",
"of",
"the",
"cover",
"glass",
"is",
"facing",
"up",
"."
]
}
] |
PMC9429973
|
Best overall response rate was 82.4 %, including 66.2% complete remissions (CR).
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Best",
"overall",
"response",
"rate",
"was",
"82.4",
"%",
",",
"including",
"66.2",
"%",
"complete",
"remissions",
"(",
"CR",
")",
"."
]
}
] |
PMC11774251
|
We performed in vivo experiments on IMQ-treated mice, applying Tan-I or a vehicle topically once daily for six days to examine the effects of Tan-I (Figure 1B).
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"We",
"performed",
"in",
"vivo",
"experiments",
"on",
"IMQ-treated",
"mice",
",",
"applying",
"Tan-I",
"or",
"a",
"vehicle",
"topically",
"once",
"daily",
"for",
"six",
"days",
"to",
"examine",
"the",
"effects",
"of",
"Tan-I",
"(",
"Figure",
"1B",
")",
"."
]
}
] |
PMC2944824
|
To conduct terminal transferase-mediated biotinylated-UTO nick end-labeling (TUNEL) staining, mice were perfused with PBS/4% formaldehyde and the brains were post-fixed in the same buffer.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"To",
"conduct",
"terminal",
"transferase-mediated",
"biotinylated-UTO",
"nick",
"end-labeling",
"(",
"TUNEL",
")",
"staining",
",",
"mice",
"were",
"perfused",
"with",
"PBS/4",
"%",
"formaldehyde",
"and",
"the",
"brains",
"were",
"post-fixed",
"in",
"the",
"same",
"buffer",
"."
]
}
] |
PMC10218459
|
Comparing the cytostatics in terms of their effectiveness showed that both cytostatics were effective, but VIN has the strongest influence on both cell lines, indicated by a significantly lower IC50 (Figure 1).
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Comparing",
"the",
"cytostatics",
"in",
"terms",
"of",
"their",
"effectiveness",
"showed",
"that",
"both",
"cytostatics",
"were",
"effective",
",",
"but",
"VIN",
"has",
"the",
"strongest",
"influence",
"on",
"both",
"cell",
"lines",
",",
"indicated",
"by",
"a",
"significantly",
"lower",
"IC50",
"(",
"Figure",
"1",
")",
"."
]
}
] |
PMC11129910
|
This subtype of triple-negative breast cancer is molecularly characterized by a stem-like nature with CD44high/CD24low levels and undergoes EMT , and this is consistent with our findings.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"This",
"subtype",
"of",
"triple-negative",
"breast",
"cancer",
"is",
"molecularly",
"characterized",
"by",
"a",
"stem-like",
"nature",
"with",
"CD44high/CD24low",
"levels",
"and",
"undergoes",
"EMT",
",",
"and",
"this",
"is",
"consistent",
"with",
"our",
"findings",
"."
]
}
] |
PMC11334037
|
After overnight incubation, the cells were treated with imatinib at 0, 20, 40, 60, and 80 μmol/L for 48 h. CompuSyn software was used to calculate the combination index using the Chou-Talalay method to determine the antagonistic influence.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"After",
"overnight",
"incubation",
",",
"the",
"cells",
"were",
"treated",
"with",
"imatinib",
"at",
"0",
",",
"20",
",",
"40",
",",
"60",
",",
"and",
"80",
"μmol/L",
"for",
"48",
"h.",
"CompuSyn",
"software",
"was",
"used",
"to",
"calculate",
"the",
"combination",
"index",
"using",
"the",
"Chou-Talalay",
"method",
"to",
"determine",
"the",
"antagonistic",
"influence",
"."
]
}
] |
PMC9712534
|
The vast majority of molecules of nuclear proteins rapidly move by stochastic diffusion.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"The",
"vast",
"majority",
"of",
"molecules",
"of",
"nuclear",
"proteins",
"rapidly",
"move",
"by",
"stochastic",
"diffusion",
"."
]
}
] |
PMC11597291
|
Data analysis was performed with the WinMDI cytometry analysis software (version 2.8).
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Data",
"analysis",
"was",
"performed",
"with",
"the",
"WinMDI",
"cytometry",
"analysis",
"software",
"(",
"version",
"2.8",
")",
"."
]
}
] |
PMC11306019
|
The daily consumption of tea is estimated at about 2.5 cups, with an average of 2.5 g of tea leaves per cup (Shen and Chen, 2008; Inoue-Choi et al., 2010; Additives et al., 2018).
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"The",
"daily",
"consumption",
"of",
"tea",
"is",
"estimated",
"at",
"about",
"2.5",
"cups",
",",
"with",
"an",
"average",
"of",
"2.5",
"g",
"of",
"tea",
"leaves",
"per",
"cup",
"(",
"Shen",
"and",
"Chen",
",",
"2008",
";",
"Inoue-Choi",
"et",
"al.",
",",
"2010",
";",
"Additives",
"et",
"al.",
",",
"2018",
")",
"."
]
}
] |
PMC9024365
|
Indeed, a recent study demonstrated overlap of SD4 with early endosomes in hippocampal neurons (Martin et al., 2021), consistent with its role in clustering AMPARs that have been internalized.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Indeed",
",",
"a",
"recent",
"study",
"demonstrated",
"overlap",
"of",
"SD4",
"with",
"early",
"endosomes",
"in",
"hippocampal",
"neurons",
"(",
"Martin",
"et",
"al.",
",",
"2021",
")",
",",
"consistent",
"with",
"its",
"role",
"in",
"clustering",
"AMPARs",
"that",
"have",
"been",
"internalized",
"."
]
}
] |
PMC9429973
|
Monoclonal antibodies used: CD14, CD16, CD300e, HLA-DR, CD64, CD38, CD45.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Monoclonal",
"antibodies",
"used",
":",
"CD14",
",",
"CD16",
",",
"CD300e",
",",
"HLA-DR",
",",
"CD64",
",",
"CD38",
",",
"CD45",
"."
]
}
] |
PMC11679033
|
There is a legitimate concern about the presence of contaminants, including mycotoxins, in cannabidiol oil (CBD) and other supplements, but studies on monitoring mycotoxins in these products are rather scarce; on the other hand, the human health risk assessment methods commonly used for regulating food and pharmaceuticals have not yet been standardized for the emerging cannabis and hemp industries .
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"There",
"is",
"a",
"legitimate",
"concern",
"about",
"the",
"presence",
"of",
"contaminants",
",",
"including",
"mycotoxins",
",",
"in",
"cannabidiol",
"oil",
"(",
"CBD",
")",
"and",
"other",
"supplements",
",",
"but",
"studies",
"on",
"monitoring",
"mycotoxins",
"in",
"these",
"products",
"are",
"rather",
"scarce",
";",
"on",
"the",
"other",
"hand",
",",
"the",
"human",
"health",
"risk",
"assessment",
"methods",
"commonly",
"used",
"for",
"regulating",
"food",
"and",
"pharmaceuticals",
"have",
"not",
"yet",
"been",
"standardized",
"for",
"the",
"emerging",
"cannabis",
"and",
"hemp",
"industries",
"."
]
}
] |
PMC2777936
|
Expression of FZD5 and FZD7 proteins in NT2/D1 cells was quantified using immunoblotting on non-reducing gels.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"B-CellLine",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Expression",
"of",
"FZD5",
"and",
"FZD7",
"proteins",
"in",
"NT2/D1",
"cells",
"was",
"quantified",
"using",
"immunoblotting",
"on",
"non-reducing",
"gels",
"."
]
}
] |
PMC6948907
|
Addition and removal of acetate groups (acetylation and deacetylation) are catalyzed by these enzymes (Turner, 1991).
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Addition",
"and",
"removal",
"of",
"acetate",
"groups",
"(",
"acetylation",
"and",
"deacetylation",
")",
"are",
"catalyzed",
"by",
"these",
"enzymes",
"(",
"Turner",
",",
"1991",
")",
"."
]
}
] |
PMC6133382
|
This representative plot (F) is shown for demonstrative process purposes only.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"This",
"representative",
"plot",
"(",
"F",
")",
"is",
"shown",
"for",
"demonstrative",
"process",
"purposes",
"only",
"."
]
}
] |
PMC10571053
|
As targeted therapies are known to act as inhibitors of ABC transporters, we next characterized the ability of the FINs to act as inhibitors of P-gp or ABCG2.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"As",
"targeted",
"therapies",
"are",
"known",
"to",
"act",
"as",
"inhibitors",
"of",
"ABC",
"transporters",
",",
"we",
"next",
"characterized",
"the",
"ability",
"of",
"the",
"FINs",
"to",
"act",
"as",
"inhibitors",
"of",
"P-gp",
"or",
"ABCG2",
"."
]
}
] |
PMC11738017
|
Within the EMD subgroup in this cohort with available sBCMA data (n = 27), a high baseline sBCMA level led to even shorter survival outcomes (Figure 6B).
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Within",
"the",
"EMD",
"subgroup",
"in",
"this",
"cohort",
"with",
"available",
"sBCMA",
"data",
"(",
"n",
"=",
"27",
")",
",",
"a",
"high",
"baseline",
"sBCMA",
"level",
"led",
"to",
"even",
"shorter",
"survival",
"outcomes",
"(",
"Figure",
"6B",
")",
"."
]
}
] |
PMC11733919
|
SA-β-gal activity is presented in relative fluorescence units (RFU).
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"SA-β-gal",
"activity",
"is",
"presented",
"in",
"relative",
"fluorescence",
"units",
"(",
"RFU",
")",
"."
]
}
] |
PMC7841189
|
The mice were maintained under pathogen-free conditions at 22°C, with 40%–50% humidity and a 12-h light/dark cycle, and allowed access to food and water ad libitum.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"The",
"mice",
"were",
"maintained",
"under",
"pathogen-free",
"conditions",
"at",
"22",
"°",
"C",
",",
"with",
"40%–50",
"%",
"humidity",
"and",
"a",
"12-h",
"light/dark",
"cycle",
",",
"and",
"allowed",
"access",
"to",
"food",
"and",
"water",
"ad",
"libitum",
"."
]
}
] |
PMC9429973
|
Nipocalimab is a fully human, effectorless IgG1 monoclonal antibody in clinical development for wAIHA.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Nipocalimab",
"is",
"a",
"fully",
"human",
",",
"effectorless",
"IgG1",
"monoclonal",
"antibody",
"in",
"clinical",
"development",
"for",
"wAIHA",
"."
]
}
] |
PMC10798140
|
The resulting mixture was refluxed overnight.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"The",
"resulting",
"mixture",
"was",
"refluxed",
"overnight",
"."
]
}
] |
PMC9429973
|
23 pts (13 HMA-naïve MDS, 4 HMA-naïve CMML, 4 HMA-failure MDS, 2 HMA-failure CMML) were enrolled.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"23",
"pts",
"(",
"13",
"HMA-naïve",
"MDS",
",",
"4",
"HMA-naïve",
"CMML",
",",
"4",
"HMA-failure",
"MDS",
",",
"2",
"HMA-failure",
"CMML",
")",
"were",
"enrolled",
"."
]
}
] |
PMC6468656
|
The mRNA levels were also determined by real-time PCR with ABI StepOnePlus real-time PCR system according to the manufacturer’s instructions.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"The",
"mRNA",
"levels",
"were",
"also",
"determined",
"by",
"real-time",
"PCR",
"with",
"ABI",
"StepOnePlus",
"real-time",
"PCR",
"system",
"according",
"to",
"the",
"manufacturer",
"’s",
"instructions",
"."
]
}
] |
PMC11724582
|
Abnormalities in the signal transduction pathway of TGF-β1 are important factors in cancer development, progression, infiltration, and metastasis.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Abnormalities",
"in",
"the",
"signal",
"transduction",
"pathway",
"of",
"TGF-β1",
"are",
"important",
"factors",
"in",
"cancer",
"development",
",",
"progression",
",",
"infiltration",
",",
"and",
"metastasis",
"."
]
}
] |
PMC11173119
|
We performed spontaneous differentiation in embryoid bodies (Figure 1F) and used an immunofluorescence analysis of differentiated cells to show the expression of mesoderm markers (α-smooth muscle actin (αSMA) and the surface marker CD29), ectoderm (tubulin β 3 (TUBB3/TUJ1) and mature neural cell markers methionine aminopeptidase 2 (MAP2)), endoderm (alpha-fetoprotein (AFP), and cytokeratin 18 (CK18)) (Figure 1G).
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"We",
"performed",
"spontaneous",
"differentiation",
"in",
"embryoid",
"bodies",
"(",
"Figure",
"1F",
")",
"and",
"used",
"an",
"immunofluorescence",
"analysis",
"of",
"differentiated",
"cells",
"to",
"show",
"the",
"expression",
"of",
"mesoderm",
"markers",
"(",
"α-smooth",
"muscle",
"actin",
"(",
"αSMA",
")",
"and",
"the",
"surface",
"marker",
"CD29",
")",
",",
"ectoderm",
"(",
"tubulin",
"β",
"3",
"(",
"TUBB3/TUJ1",
")",
"and",
"mature",
"neural",
"cell",
"markers",
"methionine",
"aminopeptidase",
"2",
"(",
"MAP2",
")",
")",
",",
"endoderm",
"(",
"alpha-fetoprotein",
"(",
"AFP",
")",
",",
"and",
"cytokeratin",
"18",
"(",
"CK18",
")",
")",
"(",
"Figure",
"1",
"G",
")",
"."
]
}
] |
PMC11742047
|
For each cell line, two groups were studied (5 replicates each): non-treated cells (control at 48 h) and treated cells with pure CBD (CBD group).
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"For",
"each",
"cell",
"line",
",",
"two",
"groups",
"were",
"studied",
"(",
"5",
"replicates",
"each",
"):",
"non-treated",
"cells",
"(",
"control",
"at",
"48",
"h",
")",
"and",
"treated",
"cells",
"with",
"pure",
"CBD",
"(",
"CBD",
"group",
")",
"."
]
}
] |
PMC11551844
|
MS data were recorded using the full scanning mode from 40 to 580 (amu).
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"MS",
"data",
"were",
"recorded",
"using",
"the",
"full",
"scanning",
"mode",
"from",
"40",
"to",
"580",
"(",
"amu",
")",
"."
]
}
] |
PMC9587866
|
The active amino acids surrounding the active pocket of EYA3 was 10 and the recorded conservation score was 0.675.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"The",
"active",
"amino",
"acids",
"surrounding",
"the",
"active",
"pocket",
"of",
"EYA3",
"was",
"10",
"and",
"the",
"recorded",
"conservation",
"score",
"was",
"0.675",
"."
]
}
] |
PMC9512971
|
An important pharmacokinetic (PK) feature of camostat mesilate is that when orally administered, it is rapidly metabolized into an active metabolite (GBPA) by esterases [28–30].
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"An",
"important",
"pharmacokinetic",
"(",
"PK",
")",
"feature",
"of",
"camostat",
"mesilate",
"is",
"that",
"when",
"orally",
"administered",
",",
"it",
"is",
"rapidly",
"metabolized",
"into",
"an",
"active",
"metabolite",
"(",
"GBPA",
")",
"by",
"esterases",
"[",
"28–30",
"]",
"."
]
}
] |
PMC11566417
|
Blood collection was covered by Cornell University IACUC #2014–0038.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Blood",
"collection",
"was",
"covered",
"by",
"Cornell",
"University",
"IACUC",
"#",
"2014–0038",
"."
]
}
] |
PMC11773391
|
Among them, the use of oncolytic virus or mRNA‐based melanoma vaccines in melanoma treatment deserves special attention .
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Among",
"them",
",",
"the",
"use",
"of",
"oncolytic",
"virus",
"or",
"mRNA‐based",
"melanoma",
"vaccines",
"in",
"melanoma",
"treatment",
"deserves",
"special",
"attention",
"."
]
}
] |
PMC9429973
|
By addressing stakeholder questions, researchers can simultaneously advance the uptake of their research into practice and improve the quality of life of those with the disease.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"By",
"addressing",
"stakeholder",
"questions",
",",
"researchers",
"can",
"simultaneously",
"advance",
"the",
"uptake",
"of",
"their",
"research",
"into",
"practice",
"and",
"improve",
"the",
"quality",
"of",
"life",
"of",
"those",
"with",
"the",
"disease",
"."
]
}
] |
PMC10093184
|
The ability to form spheroids was confirmed for COS3600, COS3600B, and COS4074 cells.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"B-CellLine",
"O",
"B-CellLine",
"O",
"O",
"B-CellLine",
"O",
"O"
],
"tokens": [
"The",
"ability",
"to",
"form",
"spheroids",
"was",
"confirmed",
"for",
"COS3600",
",",
"COS3600B",
",",
"and",
"COS4074",
"cells",
"."
]
}
] |
PMC11534377
|
Longitudinal in vivo monitoring of xenograft development was executed using the IVIS SPECTRUM (Perkin Elmer, USA), using a bioluminescent reporter (IVISbrite D-luciferin, RediJect, Perkin Elmer).
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Longitudinal",
"in",
"vivo",
"monitoring",
"of",
"xenograft",
"development",
"was",
"executed",
"using",
"the",
"IVIS",
"SPECTRUM",
"(",
"Perkin",
"Elmer",
",",
"USA",
")",
",",
"using",
"a",
"bioluminescent",
"reporter",
"(",
"IVISbrite",
"D-luciferin",
",",
"RediJect",
",",
"Perkin",
"Elmer",
")",
"."
]
}
] |
PMC8414691
|
IN = input, IP = immunoprecipitation Lastly, we investigated whether the association of SRCAP with the mitotic apparatus and defects in cell division observed after its depletion are unique to human cells or are evolutionarily conserved.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"IN",
"=",
"input",
",",
"IP",
"=",
"immunoprecipitation",
"Lastly",
",",
"we",
"investigated",
"whether",
"the",
"association",
"of",
"SRCAP",
"with",
"the",
"mitotic",
"apparatus",
"and",
"defects",
"in",
"cell",
"division",
"observed",
"after",
"its",
"depletion",
"are",
"unique",
"to",
"human",
"cells",
"or",
"are",
"evolutionarily",
"conserved",
"."
]
}
] |
PMC11779960
|
In the arising paper, we described the structural basis for antibody discrimination between TRBC1 and 2 and described a TRBC2 directed therapy.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"In",
"the",
"arising",
"paper",
",",
"we",
"described",
"the",
"structural",
"basis",
"for",
"antibody",
"discrimination",
"between",
"TRBC1",
"and",
"2",
"and",
"described",
"a",
"TRBC2",
"directed",
"therapy",
"."
]
}
] |
PMC11194678
|
Representative images showing the droplets of Cy5-STAU1 (5 μM, magenta) could not enrich OSKAR 3′UTR (40 ng, green) stained by SYTO12. (
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Representative",
"images",
"showing",
"the",
"droplets",
"of",
"Cy5-STAU1",
"(",
"5",
"μM",
",",
"magenta",
")",
"could",
"not",
"enrich",
"OSKAR",
"3′UTR",
"(",
"40",
"ng",
",",
"green",
")",
"stained",
"by",
"SYTO12",
".",
"("
]
}
] |
PMC11469524
|
Phosphosites significantly regulated by p38 inhibitor SB203580 (limma, FDR≤5%).
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Phosphosites",
"significantly",
"regulated",
"by",
"p38",
"inhibitor",
"SB203580",
"(",
"limma",
",",
"FDR≤5",
"%",
")",
"."
]
}
] |
PMC9545474
|
These results suggest that the complexes have a different mode of action from that of cisplatin; such a tendency has been previously observed for arene ruthenium metal‐based drugs.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"These",
"results",
"suggest",
"that",
"the",
"complexes",
"have",
"a",
"different",
"mode",
"of",
"action",
"from",
"that",
"of",
"cisplatin",
";",
"such",
"a",
"tendency",
"has",
"been",
"previously",
"observed",
"for",
"arene",
"ruthenium",
"metal‐based",
"drugs",
"."
]
}
] |
PMC11290772
|
Lysis rate of primary ovarian tumor cells from patient #01, #02, #03 and #04 by PBMC-NK and ROBO1-NK after 24 h, detected with CCK-8 assay. (
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Lysis",
"rate",
"of",
"primary",
"ovarian",
"tumor",
"cells",
"from",
"patient",
"#",
"01",
",",
"#",
"02",
",",
"#",
"03",
"and",
"#",
"04",
"by",
"PBMC-NK",
"and",
"ROBO1-NK",
"after",
"24",
"h",
",",
"detected",
"with",
"CCK-8",
"assay",
".",
"("
]
}
] |
PMC11488203
|
Conversely, these taxol-loaded EVs/exosomes from MSC270816 displayed higher cytotoxic effects on the lower proliferating cancer cells HT-29 and CCF-STTG1 (Fig. 2D, F).
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"B-CellLine",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"B-CellLine",
"O",
"B-CellLine",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Conversely",
",",
"these",
"taxol-loaded",
"EVs/exosomes",
"from",
"MSC270816",
"displayed",
"higher",
"cytotoxic",
"effects",
"on",
"the",
"lower",
"proliferating",
"cancer",
"cells",
"HT-29",
"and",
"CCF-STTG1",
"(",
"Fig.",
"2D",
",",
"F",
")",
"."
]
}
] |
PMC11792090
|
These results indicate that E066 CAR-T cells exhibit minimal fratricide compared to P8F8 CAR-T cells.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"These",
"results",
"indicate",
"that",
"E066",
"CAR-T",
"cells",
"exhibit",
"minimal",
"fratricide",
"compared",
"to",
"P8F8",
"CAR-T",
"cells",
"."
]
}
] |
PMC11422497
|
The functional roles of circRNAs are diverse and impactful.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"The",
"functional",
"roles",
"of",
"circRNAs",
"are",
"diverse",
"and",
"impactful",
"."
]
}
] |
PMC11467964
|
For each analysis, a p < .05 was considered statistically significant.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"For",
"each",
"analysis",
",",
"a",
"p",
"<",
".05",
"was",
"considered",
"statistically",
"significant",
"."
]
}
] |
PMC6600592
|
This residue was dissolved in ethyl acetate (20 mL), then washed with saturated sodium chloride solution (20 mL × 3).
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"This",
"residue",
"was",
"dissolved",
"in",
"ethyl",
"acetate",
"(",
"20",
"mL",
")",
",",
"then",
"washed",
"with",
"saturated",
"sodium",
"chloride",
"solution",
"(",
"20",
"mL",
"×",
"3",
")",
"."
]
}
] |
PMC10706275
|
The amplified PCR fragment measured 865 base pairs in size.
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"The",
"amplified",
"PCR",
"fragment",
"measured",
"865",
"base",
"pairs",
"in",
"size",
"."
]
}
] |
PMC11352311
|
We believe that this phenomenon is due to cellular heterogeneity, which results in different effective concentrations of the same drug across various cell lines within the same disease .
|
[
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"We",
"believe",
"that",
"this",
"phenomenon",
"is",
"due",
"to",
"cellular",
"heterogeneity",
",",
"which",
"results",
"in",
"different",
"effective",
"concentrations",
"of",
"the",
"same",
"drug",
"across",
"various",
"cell",
"lines",
"within",
"the",
"same",
"disease",
"."
]
}
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.